Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease

被引:40
作者
Widner, B
Leblhuber, F
Frick, B
Laich, A
Artner-Dworzak, E
Fuchs, D
机构
[1] Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
[2] Neurol Clin Wagner Jauregg, Dept Gerontol, Linz, Austria
关键词
homocysteine; folate; neopterin; Parkinson's disease;
D O I
10.1007/s00702-002-0758-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Moderate hyperhomocysteinaemia has been linked to an increased risk for cardiovascular diseases. Increased homocysteine concentrations may follow folate depletion due to insufficient dietary intake of the vitamin, but there is also some indication that immune activation could play a role. In this preliminary study, homocysteine, folate, and vitamin B-12 concentrations were measured in 19 patients with Parkinson's disease, 61-90 years of age, and compared to a healthy control group of similar age and to neopterin concentrations as an indicator of immune activation. A subgroup of patients presented with increased homocysteine and low folate concentrations. Homocysteine levels correlated inversely with vitamins folate and B-12 and positively with neopterin concentrations. Disturbed homocysteine metabolism in Parkinson's disease may be associated with vitamin deficiency and with immune system activation which may underlie folate depletion.
引用
收藏
页码:1445 / 1452
页数:8
相关论文
共 28 条
[1]  
Alam ZI, 1997, J NEUROCHEM, V69, P1326
[2]   Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease [J].
Clarke, R ;
Smith, AD ;
Jobst, KA ;
Refsum, H ;
Sutton, L ;
Ueland, PM .
ARCHIVES OF NEUROLOGY, 1998, 55 (11) :1449-1455
[3]   An alternative view of homocysteine [J].
Dudman, NPB .
LANCET, 1999, 354 (9195) :2072-2074
[4]   Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence [J].
Eikelboom, JW ;
Lonn, E ;
Genest, J ;
Hankey, G ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) :363-375
[5]   Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? [J].
Fuchs, D ;
Jaeger, M ;
Widner, B ;
Wirleitner, B ;
Artner-Dworzak, E ;
Leblhuber, F .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (08) :691-694
[6]   THE ROLE OF NEOPTERIN AS A MONITOR OF CELLULAR IMMUNE ACTIVATION IN TRANSPLANTATION, INFLAMMATORY, INFECTIOUS, AND MALIGNANT DISEASES [J].
FUCHS, D ;
WEISS, G ;
REIBNEGGER, G ;
WACHTER, H .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1992, 29 (3-4) :307-341
[7]   Homocysteine is related to neopterin and endothelin-1 in plasma of subjects with disturbed glucose metabolism and reference subjects [J].
Gottsäter, A ;
Anwaar, I ;
Eriksson, KF ;
Mattiasson, I ;
Lindgärde, F .
ANGIOLOGY, 2000, 51 (06) :489-497
[8]   OXIDANTS AND THE CENTRAL-NERVOUS-SYSTEM - SOME FUNDAMENTAL QUESTIONS - IS OXIDANT DAMAGE RELEVANT TO PARKINSONS-DISEASE, ALZHEIMERS-DISEASE, TRAUMATIC INJURY OR STROKE [J].
HALLIWELL, B .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 :23-33
[9]   Hyperhomocysteinaemia in Parkinson's disease [J].
Kuhn, W ;
Roebroek, R ;
Blom, H ;
van Oppenraaij, D ;
Muller, T .
JOURNAL OF NEUROLOGY, 1998, 245 (12) :811-812
[10]   Activated immune system in patients with Huntington's disease [J].
Leblhuber, F ;
Walli, J ;
Jellinger, K ;
Tilz, GP ;
Widner, B ;
Laccone, F ;
Fuchs, D .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (10) :747-750